Old Web
English
Sign In
Acemap
>
authorDetail
>
Mike Reich
Mike Reich
Genentech
Pharmacology
Ranibizumab
Biology
Medicine
Pharmacokinetics
5
Papers
140
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo
2007
Experimental Eye Research
John Lowe
James Araujo
Jihong Yang
Mike Reich
Amy Oldendorp
Vanessa Shiu
Valerie Quarmby
Henry B. Lowman
Samantha Lien
Jacques Gaudreault
Mauricio Maia
Show All
Source
Cite
Save
Citations (126)
Choosing the right dose and regimen PK/PD modeling of tumor response of trastuzumab-MCC-DM1 using mouse models
2007
Cancer Research
Nelson L. Jumbe
Jay Tibbitts
Leipold Doug
Mark X. Sliwkowski
Debra L. Dugger
Lisa Crocker
Mike Reich
Paul J. Fielder
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetic study of ranibizumab (LucentisTM) following subconjunctival, intracameral and intravitreal administration in rabbits
2004
Investigative Ophthalmology & Visual Science
L. A. Damico
Jacques Gaudreault
B.C. Bender
Jeriza Rusit
Mike Reich
Amy Oldendorp
P.C. Haughney
Show All
Source
Cite
Save
Citations (1)
A Pharmacokinetic Model Describing Ocular And Systemic Disposition Of Ranibizumab In Rabbits
2004
Investigative Ophthalmology & Visual Science
Jacques Gaudreault
L. A. Damico
P.C. Haughney
Mike Reich
Jeriza Rusit
B.B. Bender
Show All
Source
Cite
Save
Citations (2)
Dose schedule of recombinant murine thrombopoietin prior to myelosuppressive and myeloablative therapy in mice
2001
Cancer Chemotherapy and Pharmacology
Eric Stefanich
Catherine Carlson-Zermeno
Karen McEvoy
Mike Reich
Paul J. Fielder
Show All
Source
Cite
Save
Citations (11)
1
map